Pharmacology of the hypothermic response to 5-HT1A receptor activation in humans

Eur J Clin Pharmacol. 1990;39(1):17-9. doi: 10.1007/BF02657050.

Abstract

The selective 5-HT1A receptor ligand ipsapirone (IPS) caused dose-related hypothermia in humans. The response was attenuated by the nonselective 5-HT1/2 receptor antagonist metergoline and was completely antagonized by the nonselective beta-adrenoceptor antagonist pindolol, which interacts stereoselectively with the 5-HT1A receptor. The selective beta 1-adrenergic antagonist betaxolol had no effect. The findings indicate that IPS-induced hypothermia specifically involves activation of (presynaptic) 5-HT1A receptors. Therefore, the hypothermic response to IPS may provide a convenient in vivo paradigma to assess the function of the presynaptic 5-HT receptor in affective disorders and its involvement in the effects of psychotropic drugs.

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology
  • Adult
  • Betaxolol / pharmacology
  • Body Temperature / drug effects*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Male
  • Metergoline / pharmacology
  • Pindolol / pharmacology
  • Pyrimidines / pharmacology
  • Receptors, Serotonin / drug effects*
  • Receptors, Serotonin / physiology
  • Serotonin Antagonists / pharmacology

Substances

  • Adrenergic beta-Antagonists
  • Pyrimidines
  • Receptors, Serotonin
  • Serotonin Antagonists
  • Metergoline
  • ipsapirone
  • Pindolol
  • Betaxolol